Bon Secours just bet $5.7 billion that surgery is leaving the hospital — what it means for your career

Dr. Ashley Hussain-Okorafor, DBA
Former lecturer and hiring-side healthcare administrator

On October 26, Bon Secours Mercy Health — a Catholic nonprofit system with 47 hospitals — signed a deal to buy Surgery Partners, the country's largest independent operator of ambulatory surgery centers, for about $5.7 billion. Public shareholders get $23.50 a share in cash, a 49% premium. When it closes (targeted for early 2027), the system adds more than 200 surgery centers, surgical hospitals, and physician practices across 30 states, along with roughly 5,000 affiliated doctors.

Let me say the quiet part out loud: a hospital system just spent $5.7 billion to buy buildings that are not hospitals. That is not a small story. It is a map of where this entire field is going.

What actually happened

The buyer is HealthSpan Partners, an affiliate of Bon Secours Mercy Health, and the deal is all cash — funded with cash on hand plus new debt. Surgery Partners keeps its name, its brand, and its Brentwood, Tennessee headquarters, and it stays a secular company rather than being folded into the Catholic ministry. Its private-equity backer, Bain Capital (which owns about 39% of the company), rolls its stake into the new entity and stays on as a partner. The transaction is expected to close in the first quarter of 2027, pending shareholder and regulatory approval.

Here's the part I want you to sit with: Bon Secours reported nearly $14 billion in operating revenue in 2025 and a 2.3% margin. It's a healthy, established system choosing to park $5.7 billion in outpatient surgery — not in a new hospital tower. That choice tells you where the leadership of a major system thinks the growth is.

This isn't one deal. It's a race.

If this were a one-off, you could shrug it off. It isn't. Over the summer, Ascension — an even bigger Catholic nonprofit — closed a $3.9 billion deal for AMSURG, another ambulatory surgery company with 300-plus locations. Tenet Healthcare keeps adding to United Surgical Partners International, already the largest surgery-center platform in the country. Bon Secours is the third big name in a short window to treat ambulatory surgery as a strategic must-have, not a nice-to-have.

Why is everyone racing to the same door? Three forces, all pointing the same direction:

• Patients want lower-cost settings. A procedure done at a surgery center usually costs less than the same procedure at a hospital — and employers and insurers have noticed.
• Payers are steering care there. Medicare has been pushing "site-neutral" payment for years, trimming what it pays for some services done in a hospital outpatient department versus a physician office or surgery center. The financial case for keeping routine surgery inside a hospital keeps getting weaker.
• Hospitals need the margin. Outpatient surgery is where the profitable, high-volume cases live — orthopedics, spine, cardiology, GI, ophthalmology. Those are exactly the specialties in Surgery Partners' portfolio.

So a hospital system isn't just buying surgery centers. It's buying a pipeline of cases, a roster of physician partnerships, and a place to grow when the inpatient side is flat.

What this means for YOUR career

Here's where I get direct, because this is the part most news coverage skips. The jobs in this field follow the money. If surgery is moving out of the hospital and into ambulatory centers, then the administration jobs are moving with it — scheduling, billing, credentialing, quality, payer contracting, and operations leadership in outpatient settings.

Three things I'd do if I were you right now:

• Learn the vocabulary of outpatient operations. When an interviewer mentions "case volume," "block time," "physician joint ventures," or "payer mix," you should not blink. These are the metrics that run a surgery center, and they're different from the inpatient metrics a hospital runs on.
• Stop treating ambulatory care as a side quest. A lot of people chase the big hospital system job and ignore the surgery center or the physician-practice management company. Read this deal again: the growth is in the ambulatory side. You want to be where the growth is.
• Watch the physician relationship angle. Surgery centers live or die on their doctors, and many of them are structured as joint ventures where physicians own a piece. Administrators who can manage with physicians rather than around them are worth more in this setting than almost anywhere else.

The honest caveat

I won't oversell a deal that hasn't closed. It still needs regulatory and shareholder approval, and big healthcare deals do fall apart. And one detail worth knowing before you repeat this story: the $23.50 a share is actually below the $25.75 a share Bain proposed back in early 2025, and an independent committee said in mid-2025 that the company might be worth more standing alone. So this isn't a story about anyone overpaying out of desperation — it's a story about a big system deciding the outpatient future is worth $5.7 billion, and being right that everyone else is heading there too.

I've been in this field long enough to tell you: the safest way to read news like this is as a signal about where to aim. And every signal right now — from CMS payment rules to these multi-billion-dollar deals — is pointing at the same place. Care is moving out of the hospital building. Make sure your skills are moving with it.

Source: Becker's Hospital Review, "Bon Secours Mercy Health affiliate to acquire Surgery Partners for $5.7B" (Oct. 26, 2026), with deal terms confirmed by Bloomberg and STAT News.